Metabolic control of PPAR activity by aldehyde dehydrogenase regulates invasive cell behavior and predicts survival in hepatocellular and renal clear cell carcinoma-Reference-Cited by-同舟云学术

Metabolic control of PPAR activity by aldehyde dehydrogenase regulates invasive cell behavior and predicts survival in hepatocellular and renal clear cell carcinoma

Published:2018-11-28 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Andrejeva Diana,Kugler Jan-Michael,Nguyen Hung Thanh,Malmendal Anders,Holm Mette Lind,Toft Birgitte Groenkaer,Loya Anand C.,Cohen Stephen M.^ORCID

Funder

Novo Nordisk Fonden

Neye Foundation

Kong Christian den Tiendes Fond

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-5061-7.pdf

Reference47 articles.

1. Pavlova NN, Thompson CB. The emerging hallmarks of Cancer metabolism. Cell Metab. 2016;23:27–47.

2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.

3. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008;452:230–3.

4. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462:739–44.

5. Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, Edwards CR, Khanin R, Figueroa ME, Melnick A, et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature. 2012;483:474–8.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knockdown of PGBD5 inhibits the malignant progression of glioma through upregulation of the PPAR pathway;International Journal of Oncology;2024-04-05

2. Roles of peroxisome proliferator‐activated receptors in hepatocellular carcinoma;Journal of Cellular and Molecular Medicine;2023-11-20

3. Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction;BMC Urology;2023-09-15

4. Targeting aldehyde dehydrogenase enzymes in combination with chemotherapy and immunotherapy: An approach to tackle resistance in cancer cells;Life Sciences;2023-05

5. Prognostic biomarkers in and selection of surgical patients with hepatocellular carcinoma;APMIS;2023-04-25